According to AstraZeneca's latest financial reports the company has $41.13 Billion USD in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $$40.87 B | 4.35% |
2023-12-31 | $$39.16 B | 5.69% |
2022-12-31 | $$37.05 B | -5.67% |
2021-12-31 | $$39.28 B | 151.23% |
2020-12-31 | $$15.63 B | 7.14% |
2019-12-31 | $$14.59 B | 3.93% |
2018-12-31 | $$14.04 B | -15.61% |
2017-12-31 | $$16.64 B | -0.16% |
2016-12-31 | $$16.66 B | -9.94% |
2015-12-31 | $$18.50 B | -5.79% |
2014-12-31 | $$19.64 B | -15.51% |
2013-12-31 | $$23.25 B | -2.89% |
2012-12-31 | $$23.94 B | 2.05% |
2011-12-31 | $$23.46 B | 0.24% |
2010-12-31 | $$23.41 B | 12.43% |
2009-12-31 | $$20.82 B | 29.65% |
2008-12-31 | $$16.06 B | 7.68% |
2007-12-31 | $$14.91 B | -3.25% |
2006-12-31 | $$15.41 B | 12.6% |
2005-12-31 | $$13.69 B | -5.56% |
2004-12-31 | $$14.49 B | 9.35% |
2003-12-31 | $$13.25 B | 18.09% |
2002-12-31 | $$11.22 B | 16.59% |
2001-12-31 | $$9.62 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Bristol-Myers Squibb BMY | $17.44 B | -57.58% | ๐บ๐ธ USA |
![]() Pfizer PFE | $90.63 B | 120.36% | ๐บ๐ธ USA |
![]() Merck MRK | $48.40 B | 17.67% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $17.64 B | -57.11% | ๐ฌ๐ง UK |
![]() Sanofi SNY | $80.51 B | 95.75% | ๐ซ๐ท France |
![]() Eli Lilly LLY | $15.84 B | -61.47% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $78.10 B | 89.90% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $49.06 B | 19.29% | ๐บ๐ธ USA |
![]() Biogen BIIB | $16.97 B | -58.72% | ๐บ๐ธ USA |
![]() Novartis NVS | $38.45 B | -6.51% | ๐จ๐ญ Switzerland |